C

Progyny, Inc. PGNY

$25.44 -$0.53-2.04% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Progyny, Inc. is a U.S.-based healthcare benefits management company focused on fertility, family-building, and women’s health benefits. The company operates within the healthcare services and digital health industries, primarily serving self-insured employers, health plans, and other large organizations seeking specialized reproductive and maternal health benefits for employees. Progyny’s core offering combines benefit plan design, provider network management, pharmacy benefit administration for fertility medications, patient advocacy, and technology-enabled care navigation. Its principal revenue drivers are fertility and family-building benefit services delivered through its Fertility Benefits Solutions platform and related pharmacy services through Progyny Rx.

Progyny was founded in 2008 and evolved from a fertility-focused benefits management company into a broader women’s health and family-building platform. The company expanded its scope beyond infertility treatment into services supporting preconception, pregnancy, postpartum care, menopause support, adoption, and surrogacy assistance. Progyny has positioned itself as a differentiated healthcare benefits provider through outcomes-based fertility management, a selective network of reproductive specialists, and integrated clinical support intended to improve treatment success rates while reducing avoidable healthcare costs for employers and health plans.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Friday, August 7, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

Price History

Loading...
52-Week Range55% of range
Low
$16.10
Current
$25.44
High
$33.07
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
212 888 3124
Address
1359 Broadway
New York, NY 10018
Country
Year Founded

Headlines

9/18/2026 - Zacks Investment Research